News
Stifel Reiterates Buy on Spyre Therapeutics, Raises Price Target to $54
26 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Stifel Maintains Buy on Spyre Therapeutics, Raises Price Target to $54
26 Mar 24
News, Price Target, Analyst Ratings
NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday
5 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Wells Fargo Upgrades Spyre Therapeutics to Overweight, Raises Price Target to $35
1 Mar 24
News, Upgrades, Price Target, Analyst Ratings
Spyre Therapeutics Q4 EPS $(4.05) Up From $(5.00) YoY
29 Feb 24
Earnings, News
Spyre Therapeutics Announces Three Abstracts Accepted For Presentation At The 19th Annual Congress Of The European Crohn's And Colitis Organization
8 Feb 24
Biotech, News, General
Press releases
Spyre Therapeutics Announces Grants of Inducement Awards
1 Apr 24
Press Releases
Spyre Therapeutics Announces Grants of Inducement Awards
1 Mar 24
Press Releases
Spyre Therapeutics Announces Three Abstracts Accepted for Presentation at the 19th Annual Congress of the European Crohn's and Colitis Organisation
8 Feb 24
Press Releases
Spyre Therapeutics Appoints Accomplished Biopharma and IBD Leader Mark C. McKenna, Former Chairman, President, and CEO of Prometheus Biosciences, to its Board of Directors
5 Feb 24
Press Releases
Spyre Therapeutics Announces Grants of Inducement Awards
2 Feb 24
Press Releases